Machine Learning

In a strategic reverse merger with Rallybio, T-cell therapy innovator Candid Therapeutics secures over $505M to advance its groundbreaking autoimmune pipeline.

A new era in hearing arrives with Cochlear's Nexa System, the world's first upgradeable implant, tackling India's vast auditory health challenges.

In a strategic move, CCC Intelligent Solutions adds former Salesforce and Informatica exec John Schweitzer to its board, signaling a major push in AI and data.

As Middle East conflict roiled markets, 24/7 on-chain gold offered an immediate safe haven, challenging the dominance of traditional financial systems.

With major trials underway for its cancer and vision drugs, NovaBridge's upcoming investor presentation could be a pivotal moment for the biotech firm.

Zoetis is acquiring Neogen's genomics unit for $160M, a strategic move set to accelerate data-driven innovation in livestock and companion animal care.

With a strong cash position and promising drug candidate, Apogee Therapeutics is advancing multiple trials to challenge the I&I market with a new therapy.

Amid soaring cyber-attack costs in Asia, cloud security firm Upwind is tripling its workforce and deploying local infrastructure to deliver real-time protection.

ProCap Financial is making waves, buying 450 Bitcoin while aggressively repurchasing its own stock to close a valuation gap. A new corporate playbook?

Lynk Pharmaceuticals reports its oral drug zemprocitinib met all goals in a late-stage study for atopic dermatitis, offering rapid itch relief and a strong safety profile.

As MSA Awareness Month begins, a novel drug from Alterity Therapeutics shows significant promise in slowing the devastating and untreatable neurodegenerative disease.

With a strong cash runway and pivotal trials underway, Sionna Therapeutics aims to revolutionize CF treatment with a novel class of NBD1 stabilizer drugs.

As childhood nearsightedness soars, a new contact lens offers hope by not just correcting vision but actively slowing its progression in key global markets.

Qubic has released Neuraxon 2.0, a bio-inspired framework using trinary logic to create 'LiveAIs' that adapt in real time, challenging static 'DeadLLMs'.

Hopes for a new Huntington's gene therapy face a major delay as the FDA rejects uniQure's current data and calls for a more rigorous, complex study.

Space42 and Viasat's new venture, Equatys, aims to connect billions with a neutral, shared satellite network, challenging rivals like Starlink and AST.

RIB Software's virtual event will gather global experts to explore how AI and connected data are tackling fragmentation and reshaping the AEC industry.

With star-studded advisory board, a new biotech firm aims to turn routine dental visits into a frontline defense against oral cancer.

At MWC 2026, pureLiFi unveiled a new device to solve 5G's indoor signal woes and demonstrated a staggering 10 Gbps LiFi connection.

HARMAN's new rugged platform brings automotive-grade safety, security, and infotainment to two-wheelers, targeting a market ripe for a tech overhaul.